History Of Dr. Clay Siegall Espouses Landmark Cancer Treatment Therapies

Development in personalized medicine could greatly influence the current standards of diagnosis, prognosis and treatment. The Human Genome Project guaranteed a revolution in the individualized treatment concept. Just as a person’s characteristics are unique to their genomic information, the origin to a disease could be correlated with the genomic sequences unique to that person. An advantage of such a therapeutic approach is diagnosing the possible susceptibility to a disease and preventing this outcome by providing drug therapies much before its outbreak.

If you or your loved one has a cancer diagnosis, you want to find the best treatment possible. Understandably, this can be overwhelming. The good news is treatments and technologies advance quickly. When researching treatment options, you'll want the most accurate and recent knowledge. To help, we've compiled information about the latest cancer treatments in greater Baltimore so you can make informed decisions and find the expert care you and your family deserve.

Some of traditional drugs may be effective in patients whose cancers have a specific molecular target, and not for other patients. To solve this problem of patient-specificity, pharmaceutical research have seen the expansion of individually tailored cancer treatment, which is an application of targeted therapy, and this is where biopharmaceuticals are. As an increasing part of the population is diagnosed with cancer and as these patients live longer, increasing care will be given to patients who have received these drugs. Moreover, in the case of cancer therapy, those drugs and especially with mABs are a promise of less side effects : recombinant DNA technology makes it possible to genetically engineer an antibody to reduce the risk of host immune response.

According to Chrystoja and Diamandis (2013), targeted genome testing is less costly than some traditional testing methods, is effective in assisting decision making for certain neoplastic medications and is useful in guiding the proper testing for certain diseases such as Lynch Syndrome. In addition, genetic makeup determines the pharmacokinetics of certain drugs and genome testing may assist in medication therapies. Studies indicate that genetic predisposition determines the effectiveness of 20% to 95% of prescribed medications (Bartlett, 2011). With DNA information, a physician can prescribe a tailored medication treatment that will benefit the

Throughout the years, a diagnosis of cancer has been an uphill battle for both patients and doctors alike. An individual faces an incurable disease that is notorious for taking away lives by the numbers. Victims of the pathogen are at risk of it spreading to other parts of the body, facing an excruciating amount of pain and eventual death. If caught in an early stage the carcinogen can be removed through various treatments. However, throughout the years treatments have been limited to patients which can cause physical, and financial hardships. It is not until the age of biotechnology and more scientific research occurred that immunotherapy became a possible treatment for those in need. Immunology has been in the scientific world since the

Genome mapping is a patient-requested service done by a specialized physician to take a sample of their DNA strand and test it for future problems that can be sneaking up on said patient. The FDA, the agency responsible for releasing new medical advancements, suggests getting the mapping done might pose

Finding a panacea for cancer will be an arduous task with a very lengthy and discouraging trial and error period. Inevitably there will be some trying hurdles to get past in search of this cancer panacea, but, one that seems to be the most difficult to get passed is the severity and variety of the case presented. Doctors see this as overwhelming and very daunting since they do not want to get a patient’s hopes up if the medicine turns out not to work, or cause things to get worse. If doctors believe they have found this new and astonishing drug that cures all cancer at all stages and they prescribe it but turns out to only make the cancer worse, they will have to live knowing that they hurt all of these people and their families forever. In

For many years now, Scientists have struggled to help medical practitioners treat their patients according to their symptoms and provided customized healthcare on a personal basis. However, how personal can medicine get? In 2003, researchers obtained a complete human genome from which the sequence and map of all genes in the human body can be used as a reference. With this development we are a step closer to treating cancer and other diseases.

It is no secret that cancer is leading cause of death in the world. It was estimated that in 2012, 14.1 million new cases of cancer occurred worldwide and 8.2 million people died as a result of cancer [1]. Cancer prevalence is increasing at an alarming rate, yet the progress of treatment has been slow, with benefits of treatment being measured in only months or even weeks. Most patients with a specific type of cancer at a certain stage will receive the exact same form of treatment, but it has been made clear that while the treatment works well for some, it does not for a significant amount of others. The treatment that patients receive today is based on

The sequencing of the human genome has a new approach to health care in regards to promotion, maintenance, and treatment. Genetic research is defined as a new approach to a better understanding of the genetic components of common diseases: Cancer, diabetes, stroke, and creating new gene-based technologies for screening, prevention, diagnosis, and treatment of both rare and common diseases. Nurses are a main aspect within the first line of care, and therefore will contribute fully in genetic-based and genomic-based practice activities such as collecting family history, obtaining informed consent for genetic testing, and administering gene-based therapies. Lea, D, (January 31, 2008). My paper is based on an article Genomics in the public

Cancer is figured to be the second leading causes of morbidity and mortality worldwide. With approximately 14 million new cases and 8.2 million cancer related deaths in 2012, alone .Why are so many people stuck suffering with this deadly disease? Millions of dollars have been invested into cancer research, yet there is no cure. Are these pharmaceutical companies focus on finding a cure for cancer or concentrating on elongated treatments in order to lengthen their pockets? We must first understand that cancer is big business earning huge profits. Nonetheless, the cancer industry is spending virtually zilch of its multi-billion dollar resources on effective prevention strategies, like dietary guidelines, exercise, natural remedies and herbs proven to cure cancer. Instead, it pours its money into treating cancer, not preventing or allaying it.

In June 2000, the publicly funded Human Genome Project (HGP) and the private firm Celera Genomics Inc. announced that they had completed sequencing the human genome. This unprecedented accomplishment is expected to enable doctors to diagnose, treat and even prevent numerous genetic diseases. As these two entities worked on sequencing the human genome, there was also a separate and less publicized race to patent as many human genes as possible.

The Human Genome Project has aimed to provide us with detailed information about the Human Genome. This will be extremely effective towards studying people with specific diseases such as heart disease, cancer, diabetes, hypertension and cystic fibrosis. The DNA sequences of any two people are actually very alike. The little difference is those that cause a high risk of an individual developing a certain disease. During the course of

There are many human medical problems that can be controlled by early detection. This program would be incredibly beneficial to the fight of those diseases. Also as a medical benefit is the possibility of gene therapy drugs that could prevent or cure disease. They also could reach as far as to eradicate many of the killers that have plagued mankind for generations. These are some of the reasons that many large companies are attempting to align themselves with other companies that have the technology to capitalize from these new findings. Projections of DNA-based products and technologies in the biotech industry are exceeding $45 billion by the year 2009.

The author, Francis S. Collins, is the man responsible for the successful completion of Human Genome Project (HGP). HGP is an international multidisciplinary scientific research project which was involved in mapping and sequencing human DNA and determining the various aspects of its function. With this incredible expertise to his credit, Dr. Collins in the book ‘The Language of Life’ talks about personalizing medicine by understanding the DNA of each individual. The author starts by narrating some real life incidents of his family members which threw light on the importance of DNA sequencing, then the author goes to talk about various situations and conditions which all implicate the importance of personalized medicine in today’s world. In this book, the author focuses on cancer, microbiome, brain disorders, aging and the genetics related with them. The main underlying point in explaining the genetics of each of the conditions is to reiterate the importance of sequencing DNA beforehand so that a personalized medicine for the disease can be developed and the disease can be treated well before its advanced stage with serious effects.